← brief for 2026-09-25 · Slowing decline

SGLT2 inhibitors, semaglutide, and finerenone in diabetic kidney disease: a Bayesian network meta-analysis

Article A Peer reviewed Meta-analysis or large trial

Key takeaways

This review compared three major drugs used to protect kidneys in people with diabetes. It looked at large trials to see which drugs work best. It found that all three drugs help slow kidney decline, giving doctors more options to choose from.

Who did this work

Zongze He (Chinese PLA General Hospital) · Xu Wang (Chinese PLA General Hospital) · Li Zhang (Chinese PLA General Hospital) · Xiangmei Chen (Chinese PLA General Hospital)

Source

Article · OpenAlex, CKD works · 2026-09-24
https://doi.org/10.3389/fphar.2026.1882227